Summary
About 20% of Europeans suffer from chronic pain, and ~60% of these patients experience inadequate pain relief from currently available analgesic drug therapies and/or suffer confounding adverse effects. Our vision in the QSPainRelief consortium is that novel drug combinations...
More information & hyperlinks
Web resources: | https://qspainrelief.eu/ |